Volume 9, Number 5—May 2003
Research
Aeromonas spp. and Traveler’s Diarrhea: Clinical Features and Antimicrobial Resistance
Jordi Vila*
, Joaquin Ruiz*, Francisco Gallardo*, Martha Vargas*, Lara Soler†, Maria José Figueras†, and Joaquin Gascon‡
, Joaquin Ruiz*, Francisco Gallardo*, Martha Vargas*, Lara Soler†, Maria José Figueras†, and Joaquin Gascon‡
Table 3
Antimicrobial susceptibility of Aeromonas spp. causing traveler’s diarrhea
| No. of isolates showing susceptibility | ||
|---|---|---|
| Antimicrobial agent |
A. veronii biotype sobria
(n=9) |
caviae
(n=7) |
| Ampicillin |
0 |
0 |
| Cefotaxime |
9 |
7 |
| Chloramphenicol |
6 |
5 |
| Ciprofloxacin |
9 |
7 |
| Nalidixic acid |
9 |
7 |
| Tetracycline |
5 |
5 |
| Trimethoprim/sulfamethoxazole | 7 | 7 |
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential